upgrade

🦠microbiology review

ELISPOT Assay

Written by the Fiveable Content Team • Last updated September 2025
Written by the Fiveable Content Team • Last updated September 2025

Definition

The ELISPOT (Enzyme-Linked Immunospot) assay is a sensitive technique used to detect and quantify the secretion of specific proteins, such as cytokines, by individual cells. It is a powerful tool for analyzing cellular immune responses and is particularly useful in the context of T lymphocytes and cellular immunity.

5 Must Know Facts For Your Next Test

  1. The ELISPOT assay allows for the detection and enumeration of individual cells secreting a specific cytokine, providing a quantitative measure of the cellular immune response.
  2. It is particularly useful for analyzing the frequency and function of antigen-specific T lymphocytes, as it can detect the production of cytokines like interferon-gamma (IFN-γ) or interleukin-2 (IL-2) by these cells.
  3. The assay involves coating a membrane-backed plate with antibodies specific to the cytokine of interest, then incubating the plate with cells that are stimulated to produce the cytokine.
  4. The secreted cytokine is captured by the antibodies on the plate, and the spots formed by the secreting cells are then detected and counted using an automated or manual system.
  5. ELISPOT assays are widely used in vaccine development, immunotherapy research, and the evaluation of cellular immune responses to infectious diseases, cancer, and autoimmune disorders.

Review Questions

  • Explain how the ELISPOT assay is used to analyze the cellular immune response mediated by T lymphocytes.
    • The ELISPOT assay is a powerful technique for quantifying the frequency and function of antigen-specific T lymphocytes by detecting the secretion of cytokines, such as IFN-γ or IL-2, by these cells. It involves stimulating T cells with a specific antigen and then capturing the secreted cytokines on a membrane-coated plate. The spots formed by the cytokine-secreting cells are then counted, providing a direct measure of the cellular immune response. This assay is widely used to evaluate T cell-mediated immunity in the context of infectious diseases, cancer, and autoimmune disorders, as well as in the development and testing of vaccines and immunotherapies.
  • Describe how the ELISPOT assay differs from the more commonly used ELISA technique and explain the advantages of the ELISPOT approach.
    • While both the ELISPOT and ELISA assays are immunoassay techniques, they differ in their approach and the information they provide. ELISA is a bulk measurement that detects and quantifies the total amount of a specific protein or molecule in a sample, whereas ELISPOT focuses on the individual cells secreting a particular cytokine or protein. The ELISPOT assay offers several advantages over ELISA: it provides a more sensitive and direct measure of the frequency of antigen-specific cells, it can detect low-frequency responses, and it allows for the analysis of the functional capabilities of individual cells. This makes the ELISPOT assay a more powerful tool for evaluating cellular immune responses, particularly in the context of T lymphocytes and cellular immunity.
  • Discuss the key role of the ELISPOT assay in the development and evaluation of vaccines and immunotherapies targeting cellular immune responses.
    • The ELISPOT assay has become an essential tool in the field of vaccine and immunotherapy research and development. By quantifying the frequency and function of antigen-specific T lymphocytes, the ELISPOT assay allows researchers to assess the cellular immune responses elicited by candidate vaccines or immunotherapies. This information is crucial for evaluating the efficacy and potency of these interventions, as well as for optimizing their design and formulation. The ELISPOT assay enables the identification of immunodominant antigens, the characterization of T cell responses, and the monitoring of changes in cellular immunity over time. This valuable data helps guide the selection of promising vaccine or immunotherapy candidates and informs the development of more effective strategies for modulating cellular immune responses in the context of infectious diseases, cancer, and autoimmune disorders.